|
审核状态: Project audit state: |
通过审核 Successful |
|
注册号: Registration number: |
ChiCTR2400089557 |
|
最近更新日期: Date of Last Refreshed on: |
2024-09-10 23:19:20 |
|
注册时间: Date of Registration: |
2024-09-10 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
基于机器学习建立金黄色葡萄球菌肺炎评分表:一项前瞻性多中心研究 |
|
Public title: |
Establishing a scoring system for Staphylococcus aureus pneumonia using machine learning methods: a prospective multicenter study |
|
注册题目简写: |
建立金黄色葡萄球菌肺炎评分表 |
|
English Acronym: |
Establish a scoring system for Staphylococcus aureus pneumonia |
|
研究课题的正式科学名称: |
基于机器学习建立金黄色葡萄球菌肺炎评分表:一项前瞻性多中心研究 |
|
Scientific title: |
Establishing a scoring system for Staphylococcus aureus pneumonia using machine learning methods: a prospective multicenter study |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
刘勇 |
研究负责人: |
刘勇 |
|
Applicant: |
Liu Yong |
Study leader: |
Liu Yong |
|
申请注册联系人电话: Applicant telephone: |
+86 151 8194 9131 |
研究负责人电话:
Study leader's |
+86 151 8194 9131 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
616756156@qq.com |
研究负责人电子邮件: Study leader's E-mail: |
616756156@qq.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
http://www.ctxcyy.cn/ |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
http://www.ctxcyy.cn/ |
|
申请注册联系人通讯地址: |
四川省凉山彝族自治州西昌市朝阳东路1号 |
研究负责人通讯地址: |
四川省凉山彝族自治州西昌市朝阳东路1号 |
|
Applicant address: |
No.1 Chaoyang East Road, Xichang City, Liangshan Yi Autonomous Prefecture, Sichuan Province |
Study leader's address: |
No.1 Chaoyang East Road, Xichang City, Liangshan Yi Autonomous Prefecture, Sichuan Province |
|
申请注册联系人邮政编码: Applicant postcode: |
615000 |
研究负责人邮政编码: Study leader's postcode: |
615000 |
|
申请人所在单位: |
川投西昌医院 |
||
|
Applicant's institution: |
Chuantou Xichang Hospital |
||
|
研究负责人所在单位: |
川投西昌医院 |
||
|
Affiliation of the Leader: |
Chuantou Xichang Hospital |
||
|
是否获伦理委员会批准: |
是 |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
伦审2024年第4号 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
川投西昌医院医学伦理委员会 |
||
|
Name of the ethic committee: |
Medical Ethics Committee of ChuanTou Xichang Hospital |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2024-04-25 00:00:00 | ||
|
伦理委员会联系人: |
杨霞 |
||
|
Contact Name of the ethic committee: |
Yang Xia |
||
|
伦理委员会联系地址: |
四川省凉山彝族自治州西昌市朝阳东路1号 |
||
|
Contact Address of the ethic committee: |
No.1 Chaoyang East Road, Xichang City, Liangshan Yi Autonomous Prefecture, Sichuan Province |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+86 834 717 2651 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
|
|
研究实施负责(组长)单位: |
川投西昌医院 |
||||||||||||||||||||||
|
Primary sponsor: |
Chuantou Xichang Hospital |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
四川省凉山彝族自治州西昌市朝阳东路1号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
No.1 Chaoyang East Road, Xichang City, Liangshan Yi Autonomous Prefecture, Sichuan Province |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
2024 四川省医学科研项目 |
||||||||||||||||||||||
|
Source(s) of funding: |
2024 Sichuan Medical Research Project |
||||||||||||||||||||||
|
研究疾病: |
金黄色葡萄球菌肺炎 |
||||||||||||||||||||||
|
Target disease: |
Staphylococcus aureus pneumonia |
||||||||||||||||||||||
|
研究疾病代码: |
J18.9 |
||||||||||||||||||||||
|
Target disease code: |
J18.9 |
||||||||||||||||||||||
|
研究类型: |
诊断试验 |
||||||||||||||||||||||
|
Study type: |
Diagnostic test |
||||||||||||||||||||||
|
研究所处阶段: |
其它 | ||||||||||||||||||||||
|
Study phase: |
N/A |
||||||||||||||||||||||
|
研究设计: |
诊断试验诊断准确性 |
||||||||||||||||||||||
|
Study design: |
Diagnostic test for accuracy |
||||||||||||||||||||||
|
研究目的: |
临床工作中仍然迫切需要一个针对金黄色葡萄球菌肺炎(staphylococcal aureus pneumonia)的早期诊断方案,来协助医生在第一时间精确地推断病原种类,指导医生及时调整抗生素。 |
||||||||||||||||||||||
|
Objectives of Study: |
There is still an urgent need for an early diagnostic plan for Staphylococcus aureus pneumonia in clinical practice to assist doctors in accurately inferring the type of pathogen in the first place and guiding them to adjust antibiotics in a timely manner. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
我们拟纳入较大样本量的肺炎病例,充分考量患者的基础健康情况、症状、体征、检验、影像学等数据。使用机器学习的方法将数据标准化,对金黄色葡萄球菌感染的肺部影像学特征进行抓取,并通过主成分分析、聚类分析等方法来精简自变量,最终构建一个便于临床使用的金黄色葡萄球菌肺炎评分表(Staphylococcus aureus pneumonia rating scale,SAPS),来评价金黄色葡萄球菌肺炎的可能性。 |
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
We plan to include a large sample size of pneumonia cases, fully considering the patient's basic health condition, symptoms, signs, tests, imaging data, and other factors. Using machine learning methods to standardize data, capture imaging features of Staphylococcus aureus pneumonia in the lungs, and simplify independent variables through principal component analysis, cluster analysis, and other methods, ultimately constructing a Staphylococcus aureus pneumonia rating scale (SAPS) for clinical use to evaluate the possibility of Staphylococcus aureus pneumonia. |
||||||||||||||||||||||
|
纳入标准: |
年龄大于等于16岁肺炎的患者。但应具备相对完整的病历资料,包括上述年龄、基础疾病、体重指数等自变量信息。 |
||||||||||||||||||||||
|
Inclusion criteria |
Patients aged 16 years or older with pneumonia. But it should have relatively complete medical record data, including independent variables such as age, underlying disease, body mass index, etc. |
||||||||||||||||||||||
|
排除标准: |
同时患有如恶性肿瘤、严重肝肾功能不全等疾病,存在严重免疫功能不全,包括放化疗、白血病、HIV患者。已经在其他类似研究中参与过的患者,以避免数据重复和潜在的研究偏倚。进入实验后无法取得病原学结果或病原学结果与临床情况不符合的患者。 |
||||||||||||||||||||||
|
Exclusion criteria: |
Simultaneously suffering from diseases such as malignant tumors, severe liver and kidney dysfunction, and severe immune dysfunction, including radiotherapy, chemotherapy, leukemia, and HIV patients. Patients who have already participated in similar studies to avoid data duplication and potential research bias. Patients who are unable to obtain pathogenic results or whose pathogenic results do not match clinical conditions after entering the experiment. |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2024-06-01 00:00:00至 To 2026-06-30 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2024-10-01 00:00:00 至 To 2025-12-31 00:00:00 |
|
诊断试验: Diagnostic Tests: |
|
||||||||||||||||||||||||||||
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
尚未开始 Not yet recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
无 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
None |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
公开/Public |
|
盲法: |
对统计分析人员实施盲法 |
|
Blinding: |
Statistical analysts |
|
试验完成后的统计结果(上传文件): |
|
|
Calculated Results after
|
|
|
是否共享原始数据: IPD sharing |
否No |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
无 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
Not Availabe |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
病例记录表 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
Case Record Form |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
暂未确定/Not yet |